| |
| |
|
| Insider
Information: |
Tahl Cindy |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
142,361 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$555,208 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,361 |
|
|
| Total
Value |
$555,208 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -184.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fate Therapeutics Inc |
FATE |
|
2024-01-09 |
142,361 |
2015-10-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2015-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
46,876 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2016-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,633 |
53,509 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2017-10-13 |
4 |
S |
$3.83 |
$29,074 |
D/D |
(7,591) |
45,918 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2017-10-16 |
4 |
S |
$4.10 |
$2,050 |
D/D |
(500) |
45,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
90,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-01-07 |
4 |
AS |
$16.00 |
$400,000 |
D/D |
(25,000) |
45,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-01-07 |
4 |
OE |
$1.37 |
$56,673 |
D/D |
25,000 |
70,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-02-25 |
4 |
OE |
$2.90 |
$72,500 |
D/D |
25,000 |
115,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-02-25 |
4 |
AS |
$16.07 |
$401,820 |
D/D |
(25,000) |
90,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-03-01 |
4 |
AS |
$16.15 |
$403,698 |
D/D |
(25,000) |
90,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-03-01 |
4 |
OE |
$2.90 |
$72,500 |
D/D |
25,000 |
115,418 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2019-10-15 |
4 |
S |
$14.24 |
$145,292 |
D/D |
(10,200) |
80,218 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
105,218 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-01-08 |
4 |
S |
$20.72 |
$118,085 |
D/D |
(5,700) |
99,518 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-10-01 |
4 |
AS |
$40.26 |
$1,426,065 |
D/D |
(35,000) |
99,518 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-10-01 |
4 |
OE |
$2.73 |
$95,550 |
D/D |
35,000 |
134,518 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-10-16 |
4 |
AS |
$50.25 |
$1,467,212 |
D/D |
(29,199) |
99,518 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-10-16 |
4 |
OE |
$2.73 |
$79,713 |
D/D |
29,199 |
128,717 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-11-04 |
4 |
OE |
$2.73 |
$140,647 |
D/D |
51,519 |
151,037 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-11-04 |
4 |
AS |
$50.41 |
$2,597,140 |
D/D |
(51,519) |
99,518 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-11-05 |
4 |
OE |
$2.73 |
$54,340 |
D/D |
19,282 |
118,800 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-11-05 |
4 |
AS |
$50.55 |
$976,252 |
D/D |
(19,282) |
99,518 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-08 |
4 |
S |
$114.76 |
$729,434 |
D/D |
(6,229) |
93,289 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-11 |
4 |
S |
$109.65 |
$360,587 |
D/D |
(3,254) |
90,035 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-19 |
4 |
OE |
$2.90 |
$101,500 |
D/D |
35,000 |
125,035 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
